Get the Stockscreener App
2.80
1.08%
0.03
After Hours:
2.77
-0.03
-1.07%
Bone Biologics Corp stock is traded at $2.80, with a volume of 16,174.
It is up +1.08% in the last 24 hours and down -30.52% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$2.77
Open:
$2.8
24h Volume:
16,174
Relative Volume:
0.03
Market Cap:
$1.53M
Revenue:
-
Net Income/Loss:
$-4.14M
P/E Ratio:
-0.3861
EPS:
-7.2511
Net Cash Flow:
$-4.79M
1W Performance:
-7.59%
1M Performance:
-30.52%
6M Performance:
-57.96%
1Y Performance:
-78.40%
1-Day Range:
$2.795
$2.9682
1-Week Range:
$2.65
$3.13
52-Week Range:
$2.65
$22.20
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
2.80 | 4.45M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Bone Biologics Corp Stock (BBLG) Latest News
What makes Bone Biologics Corporation Equity Warrant stock price move sharplyPost Market Trend Scanner For Smart Trading - jammulinksnews.com
Published on: 2025-07-30 16:43:12 - beatles.ru
Bone Biologics Corporation stock prediction for this weekFree Accurate Buy Point for Momentum Stocks - Newser
Using flow based indicators on Bone Biologics CorporationSecure Buy Strategy Based on Risk Parameters - Newser
Is Bone Biologics Corporation Equity Warrant building a consolidation baseSmart Risk Strategy with Entry Optimization - Newser
Price momentum metrics for Bone Biologics Corporation Equity Warrant explainedForecast Model for Intraday Buy Signals - Newser
Trend analysis for Bone Biologics Corporation this weekEntry Confirmation Based on Volatility Analysis - Newser
Applying big data sentiment scoring on Bone Biologics Corporation Equity WarrantSwing Entry Insight With Forecast Accuracy - Newser
Pattern recognition hints at Bone Biologics Corporation upsideLow Exposure Strategy with Sector Analysis - Newser
When is Bone Biologics Corporation Equity Warrant stock expected to show significant growthInvest confidently with data-driven strategies - jammulinksnews.com
How volatile is Bone Biologics Corporation Equity Warrant stock compared to the marketStock Market Forecasts For 2025 - jammulinksnews.com
What are Bone Biologics Corporation Equity Warrant company’s key revenue driversHigh-return market picks - jammulinksnews.com
Sectors Driving Future Growth for Bone Biologics Corporation StockCapital Growth Picks - Newser
How Interest Rate Changes Impact Bone Biologics Corporation Equity Warrant Stock PerformanceWealth Building Stock Portfolio - Newser
Bone Biologics Corporation Stock Support and Resistance Levels You Should KnowInvestor Friendly Risk Reward - Newser
Bone Biologics (OTC:BBLG) Stock Price Down 0.3% – What’s Next? - Defense World
Should You Buy MPG(max property group)Protected Capital Trading Plan - Newser
Is Bone Biologics Corporation a good long term investmentHigh-yield capital appreciation - Autocar Professional
Orthobiologics Market Growth in Future Scope 2025-2032 | Zimmer Biomet, Bone Biologics Corp., Globus Medical - openPR.com
What analysts say about Bone Biologics Corporation Equity Warrant stockFree Predictions - Autocar Professional
Bone Biologics Corporation Equity Warrant Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
(BBLGW) Technical Pivots with Risk Controls - news.stocktradersdaily.com
What analysts say about Bone Biologics Corporation stockOverwhelming financial success - PrintWeekIndia
Bone Biologics Corporation Stock Analysis and ForecastTriple-digit wealth increases - jammulinksnews.com
What drives Aardvark Therapeutics Inc. stock priceLightning-fast capital gains - jammulinksnews.com
What drives Bone Biologics Corporation stock priceUnprecedented profit potential - jammulinksnews.com
How Austin Gold Corp. stock reacts to Fed policy changesProtected Capital Trading Plan - beatles.ru
Best Stocks for Value Investors Premium Financial Forecasting ToolsExplosive earning power - jammulinksnews.com
What analysts say about Deluxe Corporation stockBreakthrough stock performance - jammulinksnews.com
What drives Bone Biologics Corporation Equity Warrant stock priceTremendous growth opportunities - jammulinksnews.com
Why NTRA stock is on top investor watchlistsRapid Gain Targets - Newser
Why i3 Verticals Inc. stock attracts strong analyst attentionFree Access to Group - Newser
How Bone Biologics Corporation stock performs during market volatilityROI Driven Alerts - Newser
What makes Bone Biologics Corporation stock price move sharplyMulti Bagger Alerts - Newser
When ABPWW stock expected to show significant growthIs STEL stock a good long term investment optionFree Best Stocks to Buy Today - Newser
What makes Legato Merger Corp. III stock price move sharplyFree Trading Group - Newser
What makes AGMH stock price move sharplyFree Growth Investment Group - Newser
Why Bone Biologics Corporation stock attracts strong analyst attentionCapital Efficient Investment Tips - Newser
When HOVRW stock expected to show significant growthIs WYNN stock a good long term investment optionTop Analyst Picks - Newser
Why Nu Skin Enterprises Inc. stock attracts strong analyst attentionTechnical Breakout List - Newser
Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy - Business Standard
Bone Biologics (OTC:BBLG) Shares Down 3.6% – Should You Sell? - Defense World
NBSTU SEC FilingsNewbury Street Acquisition Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Biocon Biologics gets EU nod for two drugs to treat bone diseases - Business Standard
(BBLGW) Long Term Investment Analysis - news.stocktradersdaily.com
Demineralized Bone Matrix Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034) - EIN News
Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket - inkl
Bone Biologics Secures $5M Public Offering with Potential for Additional $10M from Warrants - Stock Titan
Penny Stocks Worth WatchingJune 29th - MarketBeat
Bone Biologics (BBLG) Announces $5 Million Public Offering - GuruFocus
BBLG: Making Major Step Toward Commercialization - Research Tree
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):